1. A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Issue 3 (10th August 2022) Authors: Kumthekar, Priya U; Avram, Michael J; Lassman, Andrew B; Lin, Nancy U; Lee, Eudocia; Grimm, Sean A; Schwartz, Margaret; Bell Burdett, Kirsten L; Lukas, Rimas V; Dixit, Karan; Perron, Isabella; Zhang, Hui; Gradishar, William J; Pentsova, Elena I; Jeyapalan, Suriya; Groves, Morris D; Melisko, Miche... Journal: Neuro-oncology Issue: Volume 25:Issue 3(2023) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗